-PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023

  • William Figg

Press/Media

Period18 Jul 2023

Media coverage

2

Media coverage